ALSO NOTED: Study questions "black box" on droperidol; Amilyn gets pen-injector OK;

> A new Mayo Clinic study seems to show that the FDA's "black box" warning of irregular heartbeat on the antinausea drug droperidol may be unnecessary. Report

> Amilyn Pharmaceuticals got the FDA nod for its pen-injector form of the diabetes drug Symlin. Release

> Lupin of India bought Rubamin Lab, a contract manufacturer, for an undisclosed amount. Report

And Finally... Do TV characters typically name-drop prescription drugs? Apparently so: Brand-name drugs were part of the TV-series plots some 705 times so far this year--and though only one drug maker admits to product placement marketing, the rest may not be far behind. Report